Overview
AI-enabled antibody discovery for therapeutic development.
Details
AbCellera (Nasdaq: ABCL) discovers therapeutic antibodies using high-throughput microfluidics and ML. Partnerships with Lilly (incl. bamlanivimab), Pfizer, and Regeneron.
AI-enabled antibody discovery for therapeutic development. AbCellera (Nasdaq: ABCL) discovers therapeutic antibodies using high-throughput microfluidics and ML. Partnerships with Lilly (incl. bamlanivimab), Pfizer, and Regeneron.
AI-enabled antibody discovery for therapeutic development.
AbCellera (Nasdaq: ABCL) discovers therapeutic antibodies using high-throughput microfluidics and ML. Partnerships with Lilly (incl. bamlanivimab), Pfizer, and Regeneron.
Turn AI reports into shareable sites
Publish reports & dashboards as websites
Make AI-generated reports public, stable, and easy to update — free to start.
Try Revdoku →